Phathom Pharmaceuticals I... (PHAT)

PHAT trades at $12.21, 22.1% above the near-term max pain of $10 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$15), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for PHAT shows a downward trend from 15 to 2.5, indicating bearish sentiment or hedging activity. The 188% spread signals divergent expectations across timeframes. Most levels below 12.21 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.